These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31008597)

  • 1. Polyglutamine Solution-State Structural Propensity Is Repeat Length Dependent.
    Jakubek RS; Workman RJ; White SE; Asher SA
    J Phys Chem B; 2019 May; 123(19):4193-4203. PubMed ID: 31008597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV Resonance Raman Structural Characterization of an (In)soluble Polyglutamine Peptide.
    Jakubek RS; White SE; Asher SA
    J Phys Chem B; 2019 Feb; 123(8):1749-1763. PubMed ID: 30717595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomeric Polyglutamine Structures That Evolve into Fibrils.
    Punihaole D; Jakubek RS; Workman RJ; Marbella LE; Campbell P; Madura JD; Asher SA
    J Phys Chem B; 2017 Jun; 121(24):5953-5967. PubMed ID: 28531354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics analysis of the aggregation propensity of polyglutamine segments.
    Wen J; Scoles DR; Facelli JC
    PLoS One; 2017; 12(5):e0178333. PubMed ID: 28542401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Aggregation Free Energy Landscapes of Polyglutamine Repeats.
    Chen M; Tsai M; Zheng W; Wolynes PG
    J Am Chem Soc; 2016 Nov; 138(46):15197-15203. PubMed ID: 27786478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences.
    Lakhani VV; Ding F; Dokholyan NV
    PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the aggregation mechanism of polyglutamine peptides using replica exchange molecular dynamics simulations.
    Nakano M; Ebina K; Tanaka S
    J Mol Model; 2013 Apr; 19(4):1627-39. PubMed ID: 23288093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-like fibril formation by polyQ proteins: a critical balance between the polyQ length and the constraints imposed by the host protein.
    Scarafone N; Pain C; Fratamico A; Gaspard G; Yilmaz N; Filée P; Galleni M; Matagne A; Dumoulin M
    PLoS One; 2012; 7(3):e31253. PubMed ID: 22438863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils.
    Bulone D; Masino L; Thomas DJ; San Biagio PL; Pastore A
    PLoS One; 2006 Dec; 1(1):e111. PubMed ID: 17205115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular origin of polyglutamine aggregation in neurodegenerative diseases.
    Khare SD; Ding F; Gwanmesia KN; Dokholyan NV
    PLoS Comput Biol; 2005 Aug; 1(3):230-5. PubMed ID: 16158094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Analysis of Biomolecular Force Fields for Simulations of Polyglutamine in Solution.
    Fluitt AM; de Pablo JJ
    Biophys J; 2015 Sep; 109(5):1009-18. PubMed ID: 26331258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and dynamic studies reveal that the Ala-rich region of ataxin-7 initiates α-helix formation of the polyQ tract but suppresses its aggregation.
    Hong JY; Wang DD; Xue W; Yue HW; Yang H; Jiang LL; Wang WN; Hu HY
    Sci Rep; 2019 May; 9(1):7481. PubMed ID: 31097749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyglutamine Fibrils: New Insights into Antiparallel β-Sheet Conformational Preference and Side Chain Structure.
    Punihaole D; Workman RJ; Hong Z; Madura JD; Asher SA
    J Phys Chem B; 2016 Mar; 120(12):3012-26. PubMed ID: 26947327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and disaggregation of asparagine repeat-containing peptides.
    Lu X; Murphy RM
    J Pept Sci; 2014 Nov; 20(11):860-7. PubMed ID: 25044797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing polyglutamine conformation in the nucleating event by molecular dynamics simulations.
    Miettinen MS; Knecht V; Monticelli L; Ignatova Z
    J Phys Chem B; 2012 Aug; 116(34):10259-65. PubMed ID: 22770401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Aggregation Mechanism of PolyQ Proteins with Different Glutamine Repeat Lengths.
    Yushchenko T; Deuerling E; Hauser K
    Biophys J; 2018 Apr; 114(8):1847-1857. PubMed ID: 29694863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of cis-inhibition of polyQ fibrillation by polyP: PPII oligomers and the hydrophobic effect.
    Darnell GD; Derryberry J; Kurutz JW; Meredith SC
    Biophys J; 2009 Oct; 97(8):2295-305. PubMed ID: 19843462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards a length-dependent toxicity gradient.
    Klein FA; Pastore A; Masino L; Zeder-Lutz G; Nierengarten H; Oulad-Abdelghani M; Altschuh D; Mandel JL; Trottier Y
    J Mol Biol; 2007 Aug; 371(1):235-44. PubMed ID: 17560603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence Context Influences the Structure and Aggregation Behavior of a PolyQ Tract.
    Eftekharzadeh B; Piai A; Chiesa G; Mungianu D; García J; Pierattelli R; Felli IC; Salvatella X
    Biophys J; 2016 Jun; 110(11):2361-2366. PubMed ID: 27276254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.